Hyperthermia therapy

Hyperthermia therapy is a type of medical treatment where body tissue is exposed to high temperatures to damage and kill cancer cells. It is usually used with other forms of cancer treatment, such as radiation therapy and chemotherapy.

Overview

Hyperthermia therapy is based on the principle that cancer cells are more susceptible to damage by heat than normal cells. The heat can be applied locally to the tumor, regionally, or throughout the whole body. The temperature of the treatment can range from 104°F to 113°F.

Types of Hyperthermia Therapy

There are several types of hyperthermia therapy, including:

• Local hyperthermia: In this method, heat is applied to a small area, like a tumor, using various techniques that can deliver energy to heat the tumor. These techniques include microwave, radiofrequency, and ultrasound.

• Regional hyperthermia: In regional hyperthermia, heat is applied to large areas of the body, such as an organ, a limb, or a body cavity. This can be done using external applicators, or by circulating heated fluids directly in the region of the body.

• Whole-body hyperthermia: This method is used to treat metastatic cancer that has spread throughout the body. This can be done using several techniques, such as thermal chambers (similar to large incubators) or heated blankets.

Side Effects

The side effects of hyperthermia therapy can include burns, blisters, discomfort, and pain. In rare cases, more serious side effects such as heart and vascular disorders can occur.

Research and Effectiveness

Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. Many studies have shown a significant reduction in tumor size when hyperthermia therapy is combined with other treatments.

See Also

• Cancer treatment
• Radiation therapy
• Chemotherapy

References

Hyperthermia therapy Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.